You have 9 free searches left this month | for more free features.

Peptide YY

Showing 1 - 25 of 2,271

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Severe Obesity, Type 2 Diabetes in Obese Trial in São Paulo (Analyze basal expression incretin for immunolabeling and mRNA

Recruiting
  • Severe Obesity
  • Type 2 Diabetes Mellitus in Obese
  • Analyze basal expression incretin for immunolabeling and mRNA expression glucagon-like secretion peptide-1 (GLP-1) and peptide YY (PYY 3-36) incretins by L cells.
  • São Paulo, Brazil
    Hospital das Clinicas da Faculdade de Medicina da USP
Jul 7, 2022

Eating Disorder, Bulimia Nervosa Trial (Acipimox, Placebo)

Enrolling by invitation
  • Eating Disorder
  • Bulimia Nervosa
  • (no location specified)
Jul 19, 2022

APPETITE: linguAl PYY3-36 on aPpEtite and acuTe Energy InTakE

Not yet recruiting
  • Obesity
  • (no location specified)
Nov 2, 2021

Glycemic Response Trial in Ajman (Food (rice))

Recruiting
  • Glycemic Response
  • Food (rice)
  • Ajman, United Arab Emirates
    Rashid Centre for Diabetes and Research
Oct 24, 2022

Oral Feeding on Gastric Emptying, Gut Blood Flow, and Hormone

Active, not recruiting
  • Obesity
    • Nottingham, Notts, United Kingdom
      Queens Medical Centre
    Apr 5, 2022

    Prader-Willi Syndrome, Hyperphagia Trial in Bronx (Intranasal Oxytocin (IN-OXT), Matched Placebo)

    Recruiting
    • Prader-Willi Syndrome
    • Hyperphagia
    • Intranasal Oxytocin (IN-OXT)
    • Matched Placebo
    • Bronx, New York
      Montefiore Medical Center, Albert Einstein College of Medicine
    Feb 16, 2022

    Type 2 Diabetes Trial in Hellerup (Sevelamer, Placebo)

    Completed
    • Type 2 Diabetes Mellitus
    • Hellerup, Denmark
      Steno Diabetes Center Copenhagen, Gentofte Hospital
    Oct 12, 2021

    Feeding and Eating Disorders Trial in Athens (Test meal description changed)

    Recruiting
    • Feeding and Eating Disorders
    • Test meal description changed
    • Athens, Ohio
      Ohio University
    Jan 26, 2023

    Chronic Inflammation, Overweight Trial in Kannapolis (Placebo, Palmitoleic acid, 500 mg (Dose 1), Palmitoleic acid, 1,000 mg

    Recruiting
    • Chronic Inflammation
    • Overweight
    • Placebo
    • +2 more
    • Kannapolis, North Carolina
      University of North Carolina Nutrition Research Institute
    Sep 29, 2021

    Obesity, Weight Loss Trial in Birmingham (Empagliflozin Arm, Control Arm, Exercise capacity VO2 maximum determination)

    Not yet recruiting
    • Obesity
    • Weight Loss
    • Empagliflozin Arm
    • +3 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    May 22, 2023

    Obesity Trial in Lubbock (Saxenda®, Placebo)

    Active, not recruiting
    • Obesity
    • Lubbock, Texas
    • +1 more
    Nov 1, 2022

    Appetitive Behavior Trial (High protein ramen, Standard ramen)

    Not yet recruiting
    • Appetitive Behavior
    • High protein ramen
    • Standard ramen
    • (no location specified)
    Feb 3, 2023

    Healthy Trial in Glasgow (Bouts of Exercise)

    Not yet recruiting
    • Healthy
    • Bouts of Exercise
    • Glasgow, United Kingdom
      New Lister Building at Glasgow Royal Infirmary
    Oct 19, 2023

    Digestive Health, Gastrointestinal Health, Appetitive Behavior Trial in Montréal (OPTIZIOME® P³ HYDROLYZER® - WHEY, Placebo)

    Not yet recruiting
    • Digestive Health
    • +2 more
    • OPTIZIOME® P³ HYDROLYZER® - WHEY
    • Placebo
    • Montréal, Quebec, Canada
      McGill University, Currie Gymnasium (Exercise Metabolism and Nut
    Jul 21, 2023

    Shift Work Type Circadian Rhythm Sleep Disorder Trial in Uberlândia (With Meal during night work, Without Meal during night

    Completed
    • Shift Work Type Circadian Rhythm Sleep Disorder
    • With Meal during night work
    • +2 more
    • Uberlândia, Minas Gerais, Brazil
      Cibele Aparecida Crispim
    Feb 10, 2022

    Overweight, Healthy Trial in Hellerup (Low dose, Placebo, High dose)

    Recruiting
    • Overweight
    • Healthy
    • Low dose
    • +2 more
    • Hellerup, Denmark
      Gentofte Hospital
    Jul 2, 2022

    Obesity Trial (Endobariatric procedure)

    Not yet recruiting
    • Obesity
    • Endobariatric procedure
    • (no location specified)
    Aug 22, 2022

    Overweight and Obesity, Type 2 Diabetes Trial in Chicago (Water, Glucose, Steviol Glycosides)

    Enrolling by invitation
    • Overweight and Obesity
    • Type 2 Diabetes Mellitus
    • Water
    • +4 more
    • Naples, Florida
    • +1 more
    Dec 9, 2022

    Healthy Trial in Lisboa (Fruit juice)

    Completed
    • Healthy
    • Fruit juice
    • Lisboa, Portugal
      NOVA Medical School|Faculdade de Ciências Médicas, Universidade
    Apr 28, 2023

    Appetite Trial in Baton Rouge (Egg Breakfast, Bagel Breakfast)

    Completed
    • Appetite
    • Egg Breakfast
    • Bagel Breakfast
    • Baton Rouge, Louisiana
      Pennington Biomedical Research Center
    Sep 13, 2022

    Metabolic Disturbance, Obesity Trial in Nottingham (Regular meal pattern, Irregular meal pattern)

    Completed
    • Metabolic Disturbance
    • Obesity
    • Regular meal pattern
    • Irregular meal pattern
    • Nottingham, Nottinghamshire, United Kingdom
      The University of Nottingham
    Nov 1, 2022

    Type 2 Diabetes (T2DM) Trial (Endovascular Denervation System (Netrod))

    Not yet recruiting
    • Type 2 Diabetes Mellitus (T2DM)
    • Endovascular Denervation System (Netrod)
    • (no location specified)
    Jan 5, 2023

    Type 2 Diabetes Trial in Odense (Low carbohydrate)

    Recruiting
    • Type 2 Diabetes
    • Low carbohydrate
    • Odense, Denmark
      Odense University Hospital
    Aug 10, 2022

    Hunger Trial (Huel Powder)

    Not yet recruiting
    • Hunger
    • Huel Powder
    • (no location specified)
    Sep 24, 2023

    Eating Behavior, Overweight, Obesity Trial in Davis (Almond snack, Cereal-based snack)

    Terminated
    • Eating Behavior
    • +2 more
    • Almond snack
    • Cereal-based snack
    • Davis, California
      USDA, ARS, Western Human Nutrition Research Center
    Aug 8, 2022